TSH Biopharm Expands Rare Disease Portfolio, Unlocks New Opportunities in CNS Market
2025.5.6
...
Double Milestone for TSH Biopharm: Top 5% in Corporate Governance and Product Expansion into Macau
2025.5.1
...
.jpg)
TSH Biopharm was invited to attend the online institutional investor conference hosted by Concord Securities
2025.6.2
...
.jpg)
.jpg)
.jpg)
Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD., regarding the release of non-competition restrictions for Directors
2025.5.20
...
